RemeGen Co., Ltd.
9995.HKFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
223
Cost of Revenue
45
Gross Profit
178
Gross Margin
79.8%
Operating Income
-189
Operating Margin
-84.8%
Net Income
-191
Net Margin
-85.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-155
EBITDA Margin
-69.5%
2023
12/31/2023
Revenue
140
Cost of Revenue
33
Gross Profit
107
Gross Margin
76.5%
Operating Income
-195
Operating Margin
-139.5%
Net Income
-196
Net Margin
-140.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-162
EBITDA Margin
-116.0%
2022
12/31/2022
Revenue
100
Cost of Revenue
35
Gross Profit
65
Gross Margin
64.8%
Operating Income
-137
Operating Margin
-137.3%
Net Income
-130
Net Margin
-130.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-105
EBITDA Margin
-104.9%
2021
12/31/2021
Revenue
185
Cost of Revenue
9
Gross Profit
176
Gross Margin
95.3%
Operating Income
21
Operating Margin
11.4%
Net Income
36
Net Margin
19.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
52
EBITDA Margin
28.2%
2020
12/31/2020
Revenue
0
Cost of Revenue
0
Gross Profit
0
Gross Margin
N/A
Operating Income
-92
Operating Margin
N/A
Net Income
-95
Net Margin
N/A
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-86
EBITDA Margin
N/A